We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ANVS market cap is 67.58M. The company's latest EPS is USD -4.0736 and P/E is -1.20.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -14.86M | -10.44M | -7.81M | -7.76M | -4.39M |
| Net Income | -14.72M | -22.21M | -1.07M | -5.02M | -12.64M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.61M | -6.64M | -14.54M | -25.51M | -45.04M |
| Net Income | -991k | -5.46M | -14.49M | -25.33M | -56.2M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.22M | 10.21M | 7.81M | 5.05M | 14.36M |
| Total Liabilities | 3.57M | 17.96M | 11.17M | 6.8M | 7.3M |
| Total Equity | 6.66M | -7.75M | -3.35M | -1.75M | 7.06M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.12M | 8.12M | 46M | 36.02M | 10.21M |
| Total Liabilities | 2.62M | 578k | 1.51M | 7.7M | 17.96M |
| Total Equity | -8.58M | 7.54M | 44.5M | 28.32M | -7.75M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -30.6M | -39.97M | -7.03M | -10.41M | -13.61M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 8.58M | 17.34M | 4.42M | 8.65M | 20.49M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -477k | -3.97M | -9.13M | -17.31M | -39.97M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 444k | 12.04M | 46.74M | 5k | 17.34M |
| Market Cap | 67.58M |
| Price to Earnings Ratio | -1.20 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 11.68 |
| Price to Book Ratio | -8.67 |
| Dividend Yield | - |
| Shares Outstanding | 13.8M |
| Average Volume (1 week) | 184.61k |
| Average Volume (1 Month) | 487.04k |
| 52 Week Change | -57.11% |
| 52 Week High | 20.00 |
| 52 Week Low | 4.21 |
| Spread (Intraday) | 0.14 (2.86%) |
| Company Name | Annovis Bio Inc |
| Address |
1111b s governors avenue dover, delaware 19904 |
| Website | https://www.annovisbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
